CA2364209A1 - 49 proteines secretees humaines - Google Patents
49 proteines secretees humaines Download PDFInfo
- Publication number
- CA2364209A1 CA2364209A1 CA002364209A CA2364209A CA2364209A1 CA 2364209 A1 CA2364209 A1 CA 2364209A1 CA 002364209 A CA002364209 A CA 002364209A CA 2364209 A CA2364209 A CA 2364209A CA 2364209 A1 CA2364209 A1 CA 2364209A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- polypeptide
- sequence
- human
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
L'invention concerne de nouvelles protéines sécrétées humaines et des acides nucléiques contenant les régions codantes des gènes qui codent pour ces protéines. L'invention concerne également des vecteurs, des cellules hôtes, des anticorps et des procédés recombinants permettant de produire des protéines sécrétées humaines. L'invention concerne en outre des méthodes de diagnostic et de traitement permettant de diagnostiquer et de traiter les maladies, troubles et/ou états pathologiques associés à ces nouvelles protéines sécrétées humaines.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12660199P | 1999-03-26 | 1999-03-26 | |
US60/126,601 | 1999-03-26 | ||
US15437399P | 1999-09-17 | 1999-09-17 | |
US60/154,373 | 1999-09-17 | ||
US17606400P | 2000-01-14 | 2000-01-14 | |
US60/176,064 | 2000-01-14 | ||
PCT/US2000/007677 WO2000063230A2 (fr) | 1999-03-26 | 2000-03-23 | 49 proteines secretees humaines |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2364209A1 true CA2364209A1 (fr) | 2000-10-26 |
Family
ID=27383444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002364209A Abandoned CA2364209A1 (fr) | 1999-03-26 | 2000-03-23 | 49 proteines secretees humaines |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1171462A2 (fr) |
JP (1) | JP2002541833A (fr) |
AU (1) | AU6745700A (fr) |
CA (1) | CA2364209A1 (fr) |
WO (1) | WO2000063230A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6573095B1 (en) | 1998-04-29 | 2003-06-03 | Genesis Research & Development Corporation Limited | Polynucleotides isolated from skin cells |
JP2004502405A (ja) * | 2000-01-25 | 2004-01-29 | ハイセック,インコーポレーテッド | トランスフォ−ミング成長因子アルファtgfアルファ様ポリペプチドおよびポリヌクレオチドに関する方法と材料 |
WO2001090357A1 (fr) * | 2000-05-24 | 2001-11-29 | Genesis Research & Development Corporation Limited | Compositions isolees des cellules cutanees et methodes d'utilisation de ces compositions |
DK1390403T3 (da) | 2001-05-25 | 2007-05-14 | Nymox Corp | Peptider afledt af nervetrådsproteiner og medicinsk anvendelse deraf |
EP1847550A3 (fr) * | 2001-07-19 | 2008-01-09 | Nymox Corporation | Peptides actives dans le traitement des tumeurs et autre conditions requérant la suppression ou la destruction de cellules |
DE60218179T2 (de) * | 2001-07-19 | 2007-11-22 | Nymox Corp., Saint-Laurent | Peptide zur behandlung von tumoren und anderen bedingungen, die die entfernung oder zerstörung von zellen erfordern |
US7317077B2 (en) | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
KR100535543B1 (ko) * | 2002-09-13 | 2005-12-08 | 현대자동차주식회사 | 스로틀 밸브 동결 방지장치 |
US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
-
2000
- 2000-03-23 EP EP00955227A patent/EP1171462A2/fr not_active Withdrawn
- 2000-03-23 JP JP2000612320A patent/JP2002541833A/ja not_active Withdrawn
- 2000-03-23 AU AU67457/00A patent/AU6745700A/en not_active Abandoned
- 2000-03-23 CA CA002364209A patent/CA2364209A1/fr not_active Abandoned
- 2000-03-23 WO PCT/US2000/007677 patent/WO2000063230A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1171462A2 (fr) | 2002-01-16 |
WO2000063230A3 (fr) | 2001-02-08 |
JP2002541833A (ja) | 2002-12-10 |
WO2000063230A2 (fr) | 2000-10-26 |
AU6745700A (en) | 2000-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2368068A1 (fr) | 27 proteines humaines secretees | |
CA2382185A1 (fr) | 48 proteines secretees humaines | |
CA2364209A1 (fr) | 49 proteines secretees humaines | |
CA2368927A1 (fr) | Quarante-cinq proteines humaines secretees | |
CA2387696A1 (fr) | 48 proteines humaines secretees | |
CA2364630A1 (fr) | 50 proteines humaines secretees | |
CA2365223A1 (fr) | Proteines humaines secretees (46) | |
CA2368281A1 (fr) | 50 proteines humaines secretees | |
CA2368467A1 (fr) | 50 proteines humaines secretees | |
CA2391364A1 (fr) | 47 proteines humaines secretees | |
CA2364635A1 (fr) | 47 proteines humaines secretees | |
CA2365522A1 (fr) | 48 proteines secretees humaines | |
CA2368302A1 (fr) | 49 proteines secretees par un etre humain | |
CA2391361A1 (fr) | 47 proteines secretees humaines | |
CA2370441A1 (fr) | 50 proteines humaines secretees | |
CA2390946A1 (fr) | 49 proteines secretees humaines | |
CA2368442A1 (fr) | 48 proteines humaines secretees | |
CA2365247A1 (fr) | Proteines humaines secretees (49) | |
CA2368374A1 (fr) | 47 proteines humaines secretees | |
CA2368719A1 (fr) | Cinquante proteines humaines secretees | |
CA2364650A1 (fr) | Proteines humaines secretees (50) | |
CA2371172A1 (fr) | 50 proteines humaines secretees | |
CA2368916A1 (fr) | 49 proteines humaines secretees | |
CA2382769A1 (fr) | 42 proteines humaines secretees | |
CA2367620A1 (fr) | Proteines humaines secretees (47) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |